99mTc-labeled PSMA inhibitors (Johns Hopkins University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name99mTc-labeled PSMA inhibitors (Johns Hopkins University)
Drug Alias Name99mTc-labeled prostate specific membrane antigen inhibitors (Johns Hopkins University)
ClassificationOther
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A